top of page
Pipeline
Using its proprietary Lateral CAR platform, Leucid Bio has developed a pipeline of assets for the treatment of solid tumours and haematological malignancies.
bottom of page
Using its proprietary Lateral CAR platform, Leucid Bio has developed a pipeline of assets for the treatment of solid tumours and haematological malignancies.